ProCE Banner Activity

Analysis of Healthcare Provider Management of Immune-Related Adverse Events and Concordance With NCCN Guidelines

PDF

This poster, presented at the 2024 ASCO Annual Meeting, illustrates discordance between healthcare professionals and NCCN guidelines in optimal management of immune-related adverse events related to immune checkpoint inhibitor–based therapy in patients with various malignancies.

Released: June 03, 2024

Expiration: June 02, 2025

Share

Faculty

John A. Thompson

John A. Thompson, MD

Professor of Medicine
Division of Medical Oncology
University of Washington
Seattle, Washington